Hyperammonemia is a known side effect of which of the following medications?
Hemoperfusion with charcoal is useful in poisoning with which of the following substances?
What is the drug of choice for paracetamol overdose?
A patient being treated for a psychiatric disorder takes an overdose of a drug and develops bradycardia, hypotension, decreased sweating, and salivation. Which of the following is the likely drug?
Which of the following drugs can be safely administered to a pregnant patient?
Vitamin B12 is given in severe anemia via which route?
A 2-year-old boy presents with bloody stool following ingestion of an unknown amount of coumarin-based rat poison. He was treated with fresh frozen plasma and vitamin K due to a prolonged prothrombin time. What is the underlying mechanism for the bloody stool in this case?
Which of the following drugs can cause Systemic Lupus Erythematosus (SLE)?
What is the antidote for organophosphorus poisoning?
Olopatadine is:
Explanation: **Explanation:** **Valproate (Sodium Valproate)** is the correct answer. Hyperammonemia is a well-documented side effect of valproate therapy, occurring even in the absence of clinical liver failure [1]. **Mechanism:** Valproate induces hyperammonemia through two primary pathways: 1. **Inhibition of the Urea Cycle:** Valproate metabolites (specifically 2-propylpentanoic acid) inhibit **N-acetylglutamate synthase**, a mandatory activator of Carbamoyl Phosphate Synthetase I (the rate-limiting enzyme of the urea cycle). 2. **Carnitine Depletion:** Valproate promotes the excretion of carnitine. Reduced carnitine levels impair mitochondrial fatty acid beta-oxidation, further disrupting the urea cycle and leading to ammonia accumulation. **Analysis of Incorrect Options:** * **Amitriptyline (TCA):** Primarily associated with anticholinergic side effects (dry mouth, blurred vision), sedation, and cardiotoxicity (QT prolongation) [2]. It does not affect the urea cycle. * **Amisulpride (Atypical Antipsychotic):** Known for causing hyperprolactinemia and extrapyramidal symptoms, but not hyperammonemia. * **Olanzapine (Atypical Antipsychotic):** Major side effects include significant weight gain, metabolic syndrome, and dyslipidemia. **High-Yield Clinical Pearls for NEET-PG:** * **Valproate-Induced Hyperammonemic Encephalopathy (VHE):** Suspect this in a patient on valproate presenting with sudden confusion or lethargy despite normal LFTs (AST/ALT). * **Management:** Immediate discontinuation of the drug and administration of **L-carnitine**, which acts as an antidote by restoring mitochondrial function. * **Other Valproate Side Effects:** Hepatotoxicity (fulminant hepatitis), Pancreatitis, Teratogenicity (Neural Tube Defects), and Alopecia.
Explanation: **Explanation:** **Hemoperfusion** is an extracorporeal technique where blood is passed through a column containing an adsorbent material, typically **activated charcoal** or resin. For a drug to be effectively removed by hemoperfusion, it must have a **low volume of distribution (Vd)** and high adsorption affinity for charcoal. 1. **Why Phenytoin is Correct:** Phenytoin has a relatively low volume of distribution (~0.6 L/kg) and is highly protein-bound. While hemodialysis is ineffective for highly protein-bound drugs (as only free drug crosses the membrane), hemoperfusion can strip the drug from plasma proteins as it passes through the charcoal filter. Therefore, it is a preferred method for severe phenytoin toxicity when supportive care is insufficient. 2. **Why Other Options are Incorrect:** * **Methanol and Ethylene Glycol:** These are small, water-soluble molecules with very low molecular weights. They do not adsorb well to activated charcoal. The gold standard for their extracorporeal removal is **Hemodialysis**, which is highly efficient at clearing small, polar solutes. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Hemoperfusion (CHAMP):** **C**arbamazepine, **H**ydantoins (Phenytoin), **A**minophylline (Theophylline), **M**ethotrexate, **P**henobarbital. * **Hemodialysis vs. Hemoperfusion:** Use Hemodialysis for small, water-soluble molecules (Lithium, Alcohols, Salicylates). Use Hemoperfusion for large, lipid-soluble, or highly protein-bound molecules (Theophylline, Carbamazepine, Phenytoin). * **Limitation:** Hemoperfusion does not correct acid-base or electrolyte imbalances, whereas hemodialysis does.
Explanation: **Explanation:** **N-acetyl cysteine (NAC)** is the specific antidote and drug of choice for paracetamol (acetaminophen) toxicity. Paracetamol is normally metabolized in the liver; however, in overdose, the pathway becomes saturated, leading to the production of a toxic metabolite called **NAPQI** (N-acetyl-p-benzoquinone imine). Under normal conditions, NAPQI is neutralized by glutathione. In toxicity, glutathione stores are depleted, causing NAPQI to bind to hepatocytes, leading to hepatic necrosis. NAC works by: 1. Acting as a precursor to **Glutathione**, replenishing its stores. 2. Directly binding to and detoxifying NAPQI. *Clinical Note:* It is most effective when administered within 8–10 hours of ingestion. **Incorrect Options:** * **Protamine:** This is the specific antagonist used to reverse the anticoagulant effects of **Heparin**. * **BAL (British Anti-Lewisite/Dimercaprol):** A chelating agent used for heavy metal poisoning, specifically **Arsenic, Mercury, and Lead**. * **Magnesium hydroxide gel:** An antacid used to neutralize gastric acid; it has no role in systemic paracetamol toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Rumack-Matthew Nomogram:** Used to determine the need for NAC treatment based on plasma paracetamol levels and time since ingestion. * **Dosing:** NAC can be given orally or intravenously (IV). * **Toxicity Marker:** The earliest sign of toxicity is nausea/vomiting, but the most definitive marker of liver damage is an elevation in **ALT/AST** levels.
Explanation: ### Explanation The clinical presentation of **Amitriptyline** overdose is characterized by its multifaceted pharmacological profile, specifically its **anticholinergic** and **quinidine-like** effects. **1. Why Amitriptyline is Correct:** Amitriptyline is a Tricyclic Antidepressant (TCA). In overdose, it causes: * **Anticholinergic effects:** Decreased sweating (anhidrosis) and decreased salivation (dry mouth) due to muscarinic receptor blockade. * **Cardiovascular effects:** While TCAs often cause tachycardia initially, a severe overdose leads to **bradycardia and hypotension** due to the blockade of fast sodium channels (quinidine-like effect) in the myocardium and alpha-1 adrenergic blockade. This leads to QRS prolongation, arrhythmias, and myocardial depression. **2. Why Incorrect Options are Wrong:** * **Lithium:** Toxicity typically presents with neurological symptoms (tremors, ataxia, seizures) and gastrointestinal distress. It does not typically cause significant anticholinergic symptoms like decreased sweating/salivation. * **Selegiline:** An MAO-B inhibitor. Overdose usually leads to a hyperadrenergic state (hypertension, tachycardia, hyperthermia), the opposite of bradycardia and hypotension. * **Amphetamine:** A potent sympathomimetic. Overdose causes **increased** sweating (diaphoresis), tachycardia, hypertension, and pupillary dilation (mydriasis). **3. NEET-PG High-Yield Pearls:** * **TCA Overdose Triad:** The "3 Cs"—**C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias/QRS widening). * **ECG Marker:** A QRS duration >100 ms is a strong predictor of seizures; >160 ms predicts ventricular arrhythmias. * **Antidote:** **Sodium Bicarbonate** is the drug of choice to manage cardiotoxicity (it increases extracellular sodium and alkalinizes the blood, reducing drug binding to sodium channels). * **Distinction:** Unlike TCAs, organophosphate poisoning causes *increased* salivation and sweating (cholinergic excess).
Explanation: **Explanation:** In clinical pharmacology, drug safety during pregnancy is categorized based on the potential risk to the fetus. **Paracetamol (Acetaminophen)** is considered the analgesic and antipyretic of choice during all trimesters of pregnancy. It is classified as relatively safe because it does not possess teratogenic effects or interfere with fetal ductal closure (unlike NSAIDs). **Analysis of Options:** * **Tetracycline (Option A):** These are strictly contraindicated (Category D). They cross the placenta and chelate calcium, leading to **permanent discoloration of deciduous teeth** (yellow-brown) and inhibition of bone growth in the fetus. * **Metronidazole (Option C):** While recent data suggests it may be used for specific infections, it is traditionally avoided in the **first trimester** due to theoretical concerns regarding its mutagenic potential (though not proven in humans). It is not the "safest" among the given choices. * **Barbiturates (Option D):** These are associated with an increased risk of congenital malformations (neural tube defects) and can cause **neonatal withdrawal symptoms** and vitamin K deficiency (leading to neonatal hemorrhage) if used near term. **NEET-PG High-Yield Pearls:** * **Drug of Choice for Pain/Fever in Pregnancy:** Paracetamol. * **Safe Antibiotics:** Penicillins, Cephalosporins, and Erythromycin (except the estolate form). * **Teratogenic "Face":** Remember **Phenytoin** causes Fetal Hydantoin Syndrome (cleft lip/palate) and **Warfarin** causes Fetal Warfarin Syndrome (nasal hypoplasia). * **Avoid NSAIDs in the 3rd Trimester:** They can cause premature closure of the *ductus arteriosus* and oligohydramnios.
Explanation: **Explanation:** The correct route for administering Vitamin B12 (Cyanocobalamin/Methylcobalamin) in cases of severe anemia is **Intramuscular (IM)** [1]. **1. Why Intramuscular (IM) is the Correct Choice:** In severe megaloblastic anemia or cases involving neurological symptoms (Subacute Combined Degeneration of the Cord), rapid restoration of B12 stores is critical [1]. The IM route ensures **100% bioavailability** and bypasses the gastrointestinal absorption barriers. Most clinical cases of severe B12 deficiency are caused by malabsorption (e.g., Pernicious anemia, Gastrectomy, or IBD), where the intrinsic factor is absent or the terminal ileum is damaged, making parenteral administration mandatory for effective replenishment [1]. **2. Analysis of Incorrect Options:** * **Intravenous (IV):** While possible, it is rarely preferred because Vitamin B12 is rapidly excreted by the kidneys when given IV. The IM route creates a "depot" effect, allowing for more sustained plasma levels. * **Oral:** In severe anemia, oral absorption is too slow and unreliable. While high-dose oral B12 can work via passive diffusion in mild cases, it is contraindicated in severe deficiency or when malabsorption is the primary etiology. * **All of the above:** Incorrect because the IM route is the established clinical standard for initial "loading doses" in severe presentations. **NEET-PG High-Yield Pearls:** * **Schilling Test:** Historically used to diagnose B12 malabsorption (now largely replaced by antibody testing). * **Hypokalemia Risk:** During the initial treatment of severe megaloblastic anemia, rapid erythropoiesis can lead to a sudden drop in serum potassium. **Monitor Potassium levels** during the first 48 hours of therapy. * **Maintenance:** Once stores are replenished, life-long IM injections (usually monthly) are required if the underlying cause is irreversible (e.g., Pernicious Anemia).
Explanation: **Explanation** **1. Why Option C is Correct:** Coumarin-based rodenticides (like warfarin or superwarfarins) act as **Vitamin K antagonists**. They inhibit the enzyme **Vitamin K Epoxide Reductase (VKOR)**. This enzyme is essential for recycling oxidized Vitamin K back to its reduced form (hydroquinone). Reduced Vitamin K is a necessary cofactor for the **gamma-carboxylation** of glutamate residues on clotting **factors II, VII, IX, and X**, as well as proteins C and S. Without this post-translational modification, these factors are functionally inactive, leading to a profound coagulopathy and clinical bleeding (e.g., bloody stools). **2. Why Other Options are Incorrect:** * **Option A:** While some poisons cause corrosive injury, coumarins primarily cause systemic toxicity through anticoagulation rather than direct mucosal irritation. * **Option B:** While factors IX and X are affected, factor VIII is not vitamin K-dependent (it is produced by endothelial cells and associated with von Willebrand factor). * **Option D:** DIC involves widespread activation of the coagulation cascade and consumption of platelets/factors, usually triggered by sepsis or trauma. Coumarin toxicity is a state of factor *deficiency*, not consumption. **3. NEET-PG High-Yield Pearls:** * **Antidote:** For immediate reversal of coumarin toxicity, **Fresh Frozen Plasma (FFP)** or Prothrombin Complex Concentrate (PCC) is used to provide pre-formed factors. **Vitamin K1 (Phytonadione)** is given for sustained recovery but takes 6–24 hours to work. * **Monitoring:** Prothrombin Time (PT) and **INR** are used to monitor coumarin activity (Factor VII has the shortest half-life and is affected first). * **Superwarfarins:** Rodenticides often contain "superwarfarins" (e.g., brodifacoum) which have an extremely long half-life, requiring Vitamin K therapy for weeks or months.
Explanation: **Explanation:** The correct answer is **D. All of the above**. This question tests the concept of **Drug-Induced Lupus Erythematosus (DILE)**, a syndrome that mimics idiopathic SLE but is triggered by long-term exposure to certain medications. **Underlying Medical Concept:** DILE occurs primarily in individuals who are **"slow acetylators"** (genetically deficient in the N-acetyltransferase enzyme). These drugs are metabolized via acetylation in the liver; when this pathway is slow, reactive metabolites accumulate, leading to the formation of antinuclear antibodies. A hallmark of DILE is the presence of **Anti-histone antibodies** (found in >90% of cases), while Anti-dsDNA antibodies (common in idiopathic SLE) are usually absent. **Analysis of Options:** * **Procainamide (Option C):** This Class IA antiarrhythmic has the **highest risk** of inducing DILE. Nearly 80% of patients develop ANA, and 20% develop clinical symptoms. * **Hydralazine (Option B):** A vasodilator used in hypertension. It is the second most common cause, with the risk being dose-dependent (usually >200mg/day). * **Isoniazid (Option A):** A primary anti-tubercular drug known to cause DILE, especially in slow acetylators. **NEET-PG High-Yield Pearls:** 1. **Mnemonic (SHIP):** **S**ulfonamides, **H**ydralazine, **I**soniazid, **P**rocainamide (Other triggers: Phenytoin, Minocycline, Anti-TNF agents). 2. **Clinical Presentation:** DILE typically presents with pleuritis, pericarditis, fever, and arthralgia. Notably, **Malar rash and CNS/Renal involvement are rare** compared to idiopathic SLE. 3. **Management:** Symptoms usually resolve spontaneously within weeks of **discontinuing the offending drug**.
Explanation: **Explanation:** **Organophosphorus (OP) poisoning** occurs due to the irreversible inhibition of the enzyme **Acetylcholinesterase (AChE)**. This leads to an accumulation of acetylcholine at neuromuscular junctions and muscarinic receptors, resulting in a "cholinergic crisis." **Why Pralidoxime (PAM) is correct:** Pralidoxime is a **cholinesterase reactivator**. It works by displacing the phosphate group of the organophosphate from the active site of the AChE enzyme, thereby restoring its function. It is specifically effective at the nicotinic receptors, helping to reverse muscle paralysis and weakness. However, it must be administered before **"aging"** of the enzyme occurs (usually within 24–48 hours), after which the bond becomes permanent. **Why the other options are incorrect:** * **Adrenaline:** Used in anaphylaxis and cardiac arrest; it has no role in reversing AChE inhibition. * **Anti-dopaminergics:** These are used for psychosis or vomiting; they do not counteract cholinergic excess. * **Ephedrine:** A sympathomimetic used for hypotension or bronchodilation; it does not address the underlying pathology of OP poisoning. **High-Yield Clinical Pearls for NEET-PG:** 1. **Atropine** is the drug of choice for the **muscarinic symptoms** (DUMBELS: Diarrhea, Urination, Miosis, Bradycardia, Emesis, Lacrimation, Salivation). It is titrated until "Atropinization" (clear lungs and heart rate >80 bpm) is achieved. 2. **PAM** is specifically for **nicotinic symptoms** (muscle fasciculations and paralysis). 3. **Aging:** Once the enzyme-toxin complex "ages," oximes are no longer effective. 4. **Contraindication:** Oximes are generally avoided in **Carbamate poisoning** because the enzyme-carbamate bond is reversible and short-lived.
Explanation: **Explanation:** **Olopatadine** is a second-generation antihistamine used primarily in the management of allergic conjunctivitis and allergic rhinitis. Its efficacy stems from a **dual mechanism of action**, making Option C the correct choice. 1. **Selective H1-Receptor Antagonism:** It acts as a potent and selective antagonist at H1 receptors, providing rapid relief from symptoms like itching and redness by blocking the effects of histamine already released in the tissues. 2. **Mast Cell Stabilization:** It inhibits the degranulation of mast cells, preventing the release of inflammatory mediators (histamine, leukotrienes, and prostaglandins) in response to allergens. This provides a long-term prophylactic effect. **Why other options are incorrect:** * **Option A & B:** While Olopatadine does possess these individual properties, selecting either one alone is incomplete. In the context of competitive exams like NEET-PG, when a drug exhibits multiple pharmacodynamic actions, the "dual action" or "both" option is the most accurate clinical description. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Administration:** It is most commonly used as **topical ophthalmic drops** (0.1% or 0.2%) or as a **nasal spray**. * **Advantages:** Unlike first-generation antihistamines, it has minimal systemic absorption when used topically, leading to a superior safety profile with negligible sedative or anticholinergic side effects. * **Other Dual-Action Agents:** Similar drugs often tested include **Ketotifen**, **Azelastine**, and **Epinastine**. * **Pure Mast Cell Stabilizers:** Contrast Olopatadine with **Sodium Cromoglycate** or **Nedocromil**, which are *only* mast cell stabilizers and lack direct antihistaminic activity.
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free